Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults.

McMahon D, Lederman M, Haas DW, Haubrich R, Stanford J, Cooney E, Horton J, Kelleher D, Ross L, Cutrell A, Lee D, Spreen W, Mellors JW
Antivir Ther. 2001 6 (2): 105-14

PMID: 11491415

MeSH Terms (17)

Administration, Oral Adult Anti-HIV Agents CD4 Lymphocyte Count CD8-Positive T-Lymphocytes Dideoxynucleosides Drug Administration Schedule Drug Therapy, Combination Female Genotype HIV-1 HIV Infections HIV Protease Inhibitors Humans Male RNA, Viral Time Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links